We are analyzing https://link.springer.com/article/10.1007/s00592-015-0817-x.

Title:
Association of Sitagliptin with cardiovascular outcome in diabetic patients: a nationwide cohort study | Acta Diabetologica
Description:
Although dipeptidyl peptidase-4 (DPP-4) inhibitor improves glycemic control, the actual cardiovascular outcomes remain unclear. The objective of this cohort study was to thus evaluate the cardiovascular outcome in diabetic patients who received DPP-4 inhibitors (Sitagliptin). A total of 104,756 new diabetic patients were identified from the Taiwan National Health Insurance Research Database during the period from March 1, 2003 to December 31, 2011. Patients who received Sitagliptin therapy were included as exposures, and up to four age- and sex-matched controls were selected by risk-set sampling. Outcomes such as major adverse cardiovascular diseases (CVD) and deaths were assessed. Logistic regression models were applied to estimate the hazard ratios and 95 % CIs between DPP-4 inhibitor use and cardiovascular outcome. Over a mean of 14 months, the rates of total CVD per 1000 person-months were significantly lower in Sitagliptin users (3.41 vs. 5.17, p < 0.001), whereas other different CVDs (hazard ratio [HR] 0.59; 95 % confidence interval [CI] 0.48–0.72 for coronary heart disease; HR 0.75; 95 % CI 0.59–0.96 for ischemic stroke; HR 0.86; 95 % CI 0.45–1.65 for peripheral artery occlusive disease) and all-cause mortality (HR 0.56; 95 % CI 0.41–0.74]) were also fewer after adjustment for covariates. The results showed a favorable outcome of Sitagliptin as a class on lowering CVD incidence in patients with type 2 diabetes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Education
Non-Profit & Charity

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

article, diabetes, cardiovascular, google, scholar, patients, pubmed, sitagliptin, type, study, cas, outcomes, medical, med, chung, shan, university, cohort, taiwan, engl, research, outcome, diabetic, access, medicine, privacy, cookies, content, data, control, safety, central, department, hospital, analysis, information, publish, search, chang, dpp, inhibitors, health, glucose, intensive, authors, taichung, consent, log, journal, acta,

Topics {✒️}

kwo-chang ueng month download article/chapter horng-rong chang acute myocardial infarction jian-guo north road intensive blood-glucose control dipeptidyl-peptidase iv inhibitors full article pdf related subjects jing-yang huang acute coronary syndrome retrospective cohort study animal subjects performed nationwide cohort study privacy choices/manage cookies yung-po liaw myocardial infarction article yang intensive glucose control intensive glucose lowering chronic kidney disease animal rights disclosure potential cardiovascular effects european economic area sex-matched controls logistic regression models long-term survival dipeptidyl peptidase-4 inhibitors sandhu-minhas jk chiu-ping shang ai-lun yu ethics declarations conflict conditions privacy policy coronary heart disease long-term effects received dpp-4 inhibitors risk-set sampling accepting optional cookies article log lowering cvd incidence check access ischemic stroke cases interest directly relevant individual participants included instant access received sitagliptin therapy cardiovascular outcomes journal finder publish association cohort study

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Association of Sitagliptin with cardiovascular outcome in diabetic patients: a nationwide cohort study
         description:Although dipeptidyl peptidase-4 (DPP-4) inhibitor improves glycemic control, the actual cardiovascular outcomes remain unclear. The objective of this cohort study was to thus evaluate the cardiovascular outcome in diabetic patients who received DPP-4 inhibitors (Sitagliptin). A total of 104,756 new diabetic patients were identified from the Taiwan National Health Insurance Research Database during the period from March 1, 2003 to December 31, 2011. Patients who received Sitagliptin therapy were included as exposures, and up to four age- and sex-matched controls were selected by risk-set sampling. Outcomes such as major adverse cardiovascular diseases (CVD) and deaths were assessed. Logistic regression models were applied to estimate the hazard ratios and 95 % CIs between DPP-4 inhibitor use and cardiovascular outcome. Over a mean of 14 months, the rates of total CVD per 1000 person-months were significantly lower in Sitagliptin users (3.41 vs. 5.17, p < 0.001), whereas other different CVDs (hazard ratio [HR] 0.59; 95 % confidence interval [CI] 0.48–0.72 for coronary heart disease; HR 0.75; 95 % CI 0.59–0.96 for ischemic stroke; HR 0.86; 95 % CI 0.45–1.65 for peripheral artery occlusive disease) and all-cause mortality (HR 0.56; 95 % CI 0.41–0.74]) were also fewer after adjustment for covariates. The results showed a favorable outcome of Sitagliptin as a class on lowering CVD incidence in patients with type 2 diabetes.
         datePublished:2015-12-21T00:00:00Z
         dateModified:2015-12-21T00:00:00Z
         pageStart:461
         pageEnd:468
         sameAs:https://doi.org/10.1007/s00592-015-0817-x
         keywords:
            Sitagliptin
            Diabetes
            Cardiovascular outcome
            Mortality
            Internal Medicine
            Metabolic Diseases
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00592-015-0817-x/MediaObjects/592_2015_817_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00592-015-0817-x/MediaObjects/592_2015_817_Fig2_HTML.gif
         isPartOf:
            name:Acta Diabetologica
            issn:
               1432-5233
               0940-5429
            volumeNumber:53
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Milan
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Tsung-Yuan Yang
               affiliation:
                     name:Chung Shan Medical University Hospital
                     address:
                        name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yung-Po Liaw
               affiliation:
                     name:Chung Shan Medical University Hospital
                     address:
                        name:Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jing-Yang Huang
               affiliation:
                     name:Chung Shan Medical University
                     address:
                        name:Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Horng-Rong Chang
               affiliation:
                     name:Chung Shan Medical University Hospital
                     address:
                        name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kai-Wei Chang
               affiliation:
                     name:Chung Shan Medical University Hospital
                     address:
                        name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kwo-Chang Ueng
               affiliation:
                     name:Chung Shan Medical University Hospital
                     address:
                        name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Association of Sitagliptin with cardiovascular outcome in diabetic patients: a nationwide cohort study
      description:Although dipeptidyl peptidase-4 (DPP-4) inhibitor improves glycemic control, the actual cardiovascular outcomes remain unclear. The objective of this cohort study was to thus evaluate the cardiovascular outcome in diabetic patients who received DPP-4 inhibitors (Sitagliptin). A total of 104,756 new diabetic patients were identified from the Taiwan National Health Insurance Research Database during the period from March 1, 2003 to December 31, 2011. Patients who received Sitagliptin therapy were included as exposures, and up to four age- and sex-matched controls were selected by risk-set sampling. Outcomes such as major adverse cardiovascular diseases (CVD) and deaths were assessed. Logistic regression models were applied to estimate the hazard ratios and 95 % CIs between DPP-4 inhibitor use and cardiovascular outcome. Over a mean of 14 months, the rates of total CVD per 1000 person-months were significantly lower in Sitagliptin users (3.41 vs. 5.17, p < 0.001), whereas other different CVDs (hazard ratio [HR] 0.59; 95 % confidence interval [CI] 0.48–0.72 for coronary heart disease; HR 0.75; 95 % CI 0.59–0.96 for ischemic stroke; HR 0.86; 95 % CI 0.45–1.65 for peripheral artery occlusive disease) and all-cause mortality (HR 0.56; 95 % CI 0.41–0.74]) were also fewer after adjustment for covariates. The results showed a favorable outcome of Sitagliptin as a class on lowering CVD incidence in patients with type 2 diabetes.
      datePublished:2015-12-21T00:00:00Z
      dateModified:2015-12-21T00:00:00Z
      pageStart:461
      pageEnd:468
      sameAs:https://doi.org/10.1007/s00592-015-0817-x
      keywords:
         Sitagliptin
         Diabetes
         Cardiovascular outcome
         Mortality
         Internal Medicine
         Metabolic Diseases
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00592-015-0817-x/MediaObjects/592_2015_817_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00592-015-0817-x/MediaObjects/592_2015_817_Fig2_HTML.gif
      isPartOf:
         name:Acta Diabetologica
         issn:
            1432-5233
            0940-5429
         volumeNumber:53
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Milan
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Tsung-Yuan Yang
            affiliation:
                  name:Chung Shan Medical University Hospital
                  address:
                     name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yung-Po Liaw
            affiliation:
                  name:Chung Shan Medical University Hospital
                  address:
                     name:Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jing-Yang Huang
            affiliation:
                  name:Chung Shan Medical University
                  address:
                     name:Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Horng-Rong Chang
            affiliation:
                  name:Chung Shan Medical University Hospital
                  address:
                     name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kai-Wei Chang
            affiliation:
                  name:Chung Shan Medical University Hospital
                  address:
                     name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kwo-Chang Ueng
            affiliation:
                  name:Chung Shan Medical University Hospital
                  address:
                     name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Acta Diabetologica
      issn:
         1432-5233
         0940-5429
      volumeNumber:53
Organization:
      name:Springer Milan
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Chung Shan Medical University Hospital
      address:
         name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
         type:PostalAddress
      name:Chung Shan Medical University Hospital
      address:
         name:Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
         type:PostalAddress
      name:Chung Shan Medical University
      address:
         name:Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan
         type:PostalAddress
      name:Chung Shan Medical University Hospital
      address:
         name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
         type:PostalAddress
      name:Chung Shan Medical University Hospital
      address:
         name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
         type:PostalAddress
      name:Chung Shan Medical University Hospital
      address:
         name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Tsung-Yuan Yang
      affiliation:
            name:Chung Shan Medical University Hospital
            address:
               name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      name:Yung-Po Liaw
      affiliation:
            name:Chung Shan Medical University Hospital
            address:
               name:Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      name:Jing-Yang Huang
      affiliation:
            name:Chung Shan Medical University
            address:
               name:Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      name:Horng-Rong Chang
      affiliation:
            name:Chung Shan Medical University Hospital
            address:
               name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      name:Kai-Wei Chang
      affiliation:
            name:Chung Shan Medical University Hospital
            address:
               name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      name:Kwo-Chang Ueng
      affiliation:
            name:Chung Shan Medical University Hospital
            address:
               name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
      name:Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
      name:Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan
      name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
      name:Institute of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
      name:School of Medicine, Chung Shan Medical University, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(89)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.54s.

LINK . SPRINGER . COM {}